Tianjin Tianyao Pharmaceuticals Co Ltd (600488) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.19 Million ≈ $1.93 Million USD) by net assets (CN¥3.89 Billion ≈ $569.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600488 equity financing ratio to measure how much of total assets are equity-financed.

Tianjin Tianyao Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Tianjin Tianyao Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600488 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Tianjin Tianyao Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Tianyao Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gr. Sarantis S.A. AT:SAR	0.008x
Thinking Electronic Industrial Co Ltd TW:2428	0.046x
Cleanaway Co Ltd TW:8422	0.142x
Dogus Otomotiv Servis ve Ticaret AS IS:DOAS	-0.041x
Ls Cable & System Asia Ltd KO:229640	0.011x
Hangzhou Weiguang Electronic Co Ltd SHE:002801	0.045x
Sedlmayr Grund und Immobilien AG F:SPB	N/A
Groupe Dynamite Inc TO:GRGD	1.361x

Annual Cash Flow Conversion Efficiency for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Tianjin Tianyao Pharmaceuticals Co Ltd (600488) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.89 Billion ≈ $568.62 Million	CN¥569.37 Million ≈ $83.32 Million	0.147x	-29.76%
2023-12-31	CN¥3.75 Billion ≈ $549.23 Million	CN¥783.01 Million ≈ $114.58 Million	0.209x	+19.83%
2022-12-31	CN¥3.75 Billion ≈ $549.30 Million	CN¥653.52 Million ≈ $95.63 Million	0.174x	+109.69%
2021-12-31	CN¥3.82 Billion ≈ $558.53 Million	CN¥316.89 Million ≈ $46.37 Million	0.083x	-9.71%
2020-12-31	CN¥3.77 Billion ≈ $552.05 Million	CN¥346.88 Million ≈ $50.76 Million	0.092x	+18.02%
2019-12-31	CN¥3.59 Billion ≈ $524.74 Million	CN¥279.37 Million ≈ $40.88 Million	0.078x	+35.10%
2018-12-31	CN¥3.28 Billion ≈ $480.28 Million	CN¥189.27 Million ≈ $27.70 Million	0.058x	+2315.44%
2017-12-31	CN¥3.13 Billion ≈ $457.91 Million	CN¥-8.15 Million ≈ $-1.19 Million	-0.003x	-110.24%
2016-12-31	CN¥2.49 Billion ≈ $364.44 Million	CN¥63.32 Million ≈ $9.27 Million	0.025x	-51.92%
2015-12-31	CN¥2.45 Billion ≈ $358.33 Million	CN¥129.50 Million ≈ $18.95 Million	0.053x	-29.13%
2014-12-31	CN¥2.40 Billion ≈ $350.53 Million	CN¥178.76 Million ≈ $26.16 Million	0.075x	+105.28%
2013-12-31	CN¥2.33 Billion ≈ $340.36 Million	CN¥84.55 Million ≈ $12.37 Million	0.036x	+385.84%
2012-12-31	CN¥1.77 Billion ≈ $258.69 Million	CN¥13.23 Million ≈ $1.94 Million	0.007x	-83.92%
2011-12-31	CN¥1.69 Billion ≈ $246.84 Million	CN¥78.47 Million ≈ $11.48 Million	0.047x	-35.03%
2010-12-31	CN¥1.63 Billion ≈ $238.75 Million	CN¥116.82 Million ≈ $17.09 Million	0.072x	-74.40%
2009-12-31	CN¥1.56 Billion ≈ $227.69 Million	CN¥435.13 Million ≈ $63.67 Million	0.280x	+91.77%
2008-12-31	CN¥1.50 Billion ≈ $220.07 Million	CN¥219.31 Million ≈ $32.09 Million	0.146x	+31.22%
2007-12-31	CN¥1.46 Billion ≈ $213.75 Million	CN¥162.33 Million ≈ $23.75 Million	0.111x	+136.07%
2006-12-31	CN¥1.08 Billion ≈ $157.67 Million	CN¥50.72 Million ≈ $7.42 Million	0.047x	+145.17%
2005-12-31	CN¥1.04 Billion ≈ $152.86 Million	CN¥-108.87 Million ≈ $-15.93 Million	-0.104x	-193.30%
2004-12-31	CN¥987.47 Million ≈ $144.50 Million	CN¥110.30 Million ≈ $16.14 Million	0.112x	+128.34%
2003-12-31	CN¥935.65 Million ≈ $136.92 Million	CN¥45.77 Million ≈ $6.70 Million	0.049x	-15.24%
2002-12-31	CN¥784.51 Million ≈ $114.80 Million	CN¥45.28 Million ≈ $6.63 Million	0.058x	-42.62%
2001-12-31	CN¥714.63 Million ≈ $104.57 Million	CN¥71.87 Million ≈ $10.52 Million	0.101x	-48.14%
2000-12-31	CN¥211.75 Million ≈ $30.99 Million	CN¥41.06 Million ≈ $6.01 Million	0.194x	--

About Tianjin Tianyao Pharmaceuticals Co Ltd

SHG:600488 China Drug Manufacturers - Specialty & Generic

Market Cap

$936.30 Million

CN¥6.40 Billion CNY

Market Cap Rank

#9193 Global

#2279 in China

Share Price

CN¥5.86

Change (1 day)

+5.59%

52-Week Range

CN¥3.71 - CN¥7.79

All Time High

CN¥7.79